高流量湿化仪治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of high-flow and humidify oxygen therapy device in the treatment of chronic obstructive pulmonary disease（COPD）combined with type Ⅱrespiratory failure.Methods A total of 64 patients with COPD complicated with type Ⅱrespiratory failure who underwent clinical treatment in Hospital of Traditional Chinese Medicine Group of Bao′an District of Shenzhen City from January 2017 to December 2018 were selected as research objects.They were randomly divided into the treatment group and the control group,32 cases in each group.On the basis of conventional treatment,in the control group,low-flow oxygen was added,while in the treatment group,AIRV O2 high-flow and humidify oxygen therapy device was added.The therapeutic effect rate,arterial blood gas level between two groups were compared.Results The treatment effectiveness rate of the treatment group was 78.13%,higher than that of the control group accounting for 53.13%,the difference was statistically significant (P＜0.05).After treatment,the level of arterial carbon dioxide partial pressure (PaCO2) in the treatment group was lower than that in the control group,with statistical significance (P＜0.05).Conclusion AIRV O2 high-flow and humidify oxygen therapy device can reduce the partial pressure of PaCO2 in blood gas analysis effectively,and worthy of spreading.

Key words： High-flow and humidify oxygen therapy device Chronic obstructive pulmonary disease Respiratory failure Arterial blood gas level

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Li
	ZHOU Ji-hong
	JIAO Xiao-qiang
	YAO Kai-nan
	LI Jue-hui
	LI Zhu-yi

Cite this article:

ZHANG Li,ZHOU Ji-hong,JIAO Xiao-qiang, et al. Clinical effect of high-flow and humidify oxygen therapy device in the treatment of chronic obstructive pulmonary disease combined with typeⅡrespiratory failure[J]. 中国当代医药, 2021, 28(1): 50-52.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I1/50

[1]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2013年修订版）[J].中国医学前沿杂志（电子版），2014，6（2）：67-80.
[2]	王辰，迟春花，陈荣昌，等.慢性阻塞性肺疾病基层诊疗指南（2018年）[J].中华全科医师杂志，2018，17（11）：856-870.
[3]	郑广阳，樊荣兴，梁达强，等.经鼻呼吸湿化治疗仪在慢性呼吸衰竭中的应用[J].黑龙江医药，2018，31（5）：1146-1148.
[4]	罗艳，邓红妹.高流量氧气湿化治疗在ICU 气管插管患者拔管后的应用效果[J].中国当代医药，2018，25（25）：215-217.
[5]	高敏，韩小彤，文辉，等.经鼻高流量氧疗在成人呼吸衰竭患者中的应用进展[J].医学综述，2017，23（22）：4468-4472.
[6]	熊燕萍.不同方案治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的效果比较[J].中国当代医药，2019，26（5）：54-56.
[7]	叶曜衢，曾燕转，苏月南，等.AIRV O2无创呼吸湿化治疗仪与Trilogy100 无创呼吸机在治疗慢性阻塞性肺疾病合并呼吸衰竭患者中的疗效对比研究[J].岭南急诊医学杂志，2016，21（6）：615-616.
[8]	妥亚军，侯滨，侯学智，等.经鼻高流量氧气湿化治疗重型高原肺水肿的疗效[J].实用医学杂志，2017，33（18）：3156-3157.
[9]	Groves N，Tobin A.High flow nasal oxygen generates positive airway pressure in adult volunteers[J].Aust Crit Care，2007，20（4）：126-131.
[10]	Corley A，Caruana LR，Barnett AG，et al.Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients[J].Br J Anaesth，2011，107（6）：998-1004.
[11]	王丽娟，夏金根，杨晓军.成人经鼻高流量氧气湿化治疗的应用进展[J].中华结核和呼吸杂志，2016，39（2）：153-157.
[12]	许迎辉，李响，李哲勇，等.经鼻高流量湿化氧疗在急性呼吸衰竭中的应用效果[J].中国当代医药，2018，25（24）：75-77.
[13]	Kallstrom TJ.AARC Clinical practice guideline：oxygen therapy for adults in the acute care facility--2002 revision &update[J].Respir Care，2002，47（6）：717-720.
[14]	范永强，刘春香，王虹，等.高流量湿化氧疗仪在RICU 中应用效果观察[J].临床肺科杂志，2018，23（3）：450-452.
[15]	陈配配，董丽秀，叶波，等.高流量吸氧湿化仪与无创呼吸机对呼吸衰竭患者的疗效比较[J].中国当代医药，2017，24（2）：291-293.